2014

11/05/2014 Céline Lamort co-opted to Guerbet Board of Directors

The Board of Directors of Guerbet has co-opted Céline Lamort to the Board. The decision will be submitted to ratification at Guerbet’s next Annual General Meeting of Shareholders on 29 May 2015.

[more]


10/29/2014 Guerbet at RSNA 2014

Meet our teams at RSNA 2014 ӏ Guerbet Booth #1914 - South Building - Hall A - Level 3 ӏ November 30 - December 5 ӏ McCormick Place ӏ Chicago (USA)

[more]


10/24/2014 JFR 2014 great success

Guerbet awarded by the Antoine Béclère Center and great deal of interest for FlowSens® during the JFR 2014

[more]


10/23/2014 Third-quarter sales: +3.4% at constant exchange rates

Excluding currency effects, revenue for the nine-month period ended 30 September reached €306,0 million, up 6.1%. Annual targets confirmed.

[more]


09/29/2014 Guerbet Group receives FDA’s Drug Shortage Assistance Award

Guerbet LLC, USA (September 29, 2014)

[more]


09/25/2014 Bronze again for Guerbet at Corporate Governance Awards

For the second successive year Guerbet has been awarded the bronze prize for corporate governance prize in the “MidCaps” category*. CFO Jean-François Le Martret represented the Group at the prize ceremony staged by AGEFI**.  “We are very proud to share the podium (voted on by professional...

[more]


09/02/2014 cTACE: a new indication for Lipiodol® Ultra-Fluid in France

ANSM approves Lipiodol® Ultra-Fluid for visualization, localization and vectorization of hepatocellular carcinoma during trans-arterial chemoembolization

[more]


Displaying results 1 to 7 out of 30
<< First < Previous 1-7 8-14 15-21 22-28 29-30 Next > Last >>